|
[1]
|
van der Meijden, P.E.J. and Heemskerk, J.W.M. (2018) Platelet Biology and Functions: New Concepts and Clinical Perspectives. Nature Reviews Cardiology, 16, 166-179. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gaertner, F. and Massberg, S. (2019) Patrolling the Vascular Borders: Platelets in Immunity to Infection and Cancer. Nature Reviews Immunology, 19, 747-760. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Levin, J. (1964) Thrombocytosis Associated with Malignant Disease. Archives of Internal Medicine, 114, 497-500. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Chen, R., Jin, G., Li, W. and McIntyre, T.M. (2018) Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition. The Journal of Immunology, 201, 2154-2164. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Chen, J., Zhai, E., Yuan, Y., Wu, K., Xu, J., Peng, J., et al. (2017) Systemic Immune-Inflammation Index for Predicting Prognosis of Colorectal Cancer. World Journal of Gastroenterology, 23, 6261-6272. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Giannakeas, V., Kotsopoulos, J., Cheung, M.C., Rosella, L., Brooks, J.D., Lipscombe, L., et al. (2022) Analysis of Platelet Count and New Cancer Diagnosis over a 10-Year Period. JAMA Network Open, 5, e2141633. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Scheel, C., Onder, T., Karnoub, A. and Weinberg, R.A. (2007) Adaptation versus Selection: The Origins of Metastatic Behavior. Cancer Research, 67, 11476-11480. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Labelle, M., Begum, S. and Hynes, R.O. (2011) Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis. Cancer Cell, 20, 576-590. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Derynck, R. and Zhang, Y.E. (2003) Smad-Dependent and Smad-Independent Pathways in TGF-β Family Signalling. Nature, 425, 577-584. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Egan, K., Cooke, N. and Kenny, D. (2014) Living in Shear: Platelets Protect Cancer Cells from Shear Induced Damage. Clinical & Experimental Metastasis, 31, 697-704. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Suzuki-Inoue, K. (2006) A Novel Syk-Dependent Mechanism of Platelet Activation by the C-Type Lectin Receptor Clec-2. Blood, 107, 542-549. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Reymond, N., d’Água, B.B. and Ridley, A.J. (2013) Crossing the Endothelial Barrier during Metastasis. Nature Reviews Cancer, 13, 858-870. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Läubli, H. and Borsig, L. (2010) Selectins as Mediators of Lung Metastasis. Cancer Microenvironment, 3, 97-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Bauer, A.T., Suckau, J., Frank, K., Desch, A., Goertz, L., Wagner, A.H., et al. (2015) Von Willebrand Factor Fibers Promote Cancer-Associated Platelet Aggregation in Malignant Melanoma of Mice and Humans. Blood, 125, 3153-3163. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Takagi, S., Sasaki, Y., Koike, S., Takemoto, A., Seto, Y., Haraguchi, M., et al. (2021) Platelet-Derived Lysophosphatidic Acid Mediated LPAR1 Activation as a Therapeutic Target for Osteosarcoma Metastasis. Oncogene, 40, 5548-5558. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Mammadova-Bach, E., Gil-Pulido, J., Sarukhanyan, E., Burkard, P., Shityakov, S., Schonhart, C., et al. (2020) Platelet Glycoprotein VI Promotes Metastasis through Interaction with Cancer Cell-Derived Galectin-3. Blood, 135, 1146-1160. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhang, W., Zhou, H., Li, H., Mou, H., Yinwang, E., Xue, Y., et al. (2023) Cancer Cells Reprogram to Metastatic State through the Acquisition of Platelet Mitochondria. Cell Reports, 42, Article ID: 113147. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Palumbo, J.S., Barney, K.A., Blevins, E.A., Shaw, M.A., Mishra, A., Flick, M.J., et al. (2008) Factor XIII Transglutaminase Supports Hematogenous Tumor Cell Metastasis through a Mechanism Dependent on Natural Killer Cell Function. Journal of Thrombosis and Haemostasis, 6, 812-819. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zhang, Y., Manouchehri Doulabi, E., Herre, M., Cedervall, J., Qiao, Q., Miao, Z., et al. (2022) Platelet-Derived PDGFB Promotes Recruitment of Cancer-Associated Fibroblasts, Deposition of Extracellular Matrix and TGFβ Signaling in the Tumor Microenvironment. Cancers, 14, Article No. 1947. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Placke, T., Örgel, M., Schaller, M., Jung, G., Rammensee, H., Kopp, H., et al. (2012) Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune Cells. Cancer Research, 72, 440-448. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Zaslavsky, A.B., Adams, M.P., Cao, X., Maj, T., Choi, J.E., Stangl-Kremser, J., et al. (2020) Platelet PD-L1 Suppresses Anti-Cancer Immune Cell Activity in PD-L1 Negative Tumors. Scientific Reports, 10, Article No. 19296. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Dinkla, S., van Cranenbroek, B., van der Heijden, W.A., He, X., Wallbrecher, R., Dumitriu, I.E., et al. (2016) Platelet Microparticles Inhibit IL-17 Production by Regulatory T Cells through P-Selectin. Blood, 127, 1976-1986. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Lou, X.L., Sun, J., Gong, S.Q., et al. (2015) Interaction between Circulating Cancer Cells and Platelets: Clinical Implication. Chinese Journal of Cancer Research, 27, 450-460.
|
|
[24]
|
Thun, M.J., Jacobs, E.J. and Patrono, C. (2012) The Role of Aspirin in Cancer Prevention. Nature Reviews Clinical Oncology, 9, 259-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Lakka Klement, G., Yip, T., Cassiola, F., Kikuchi, L., Cervi, D., Podust, V., et al. (2009) Platelets Actively Sequester Angiogenesis Regulators. Blood, 113, 2835-2842. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Josa, V., Ferenczi, S., Szalai, R., Fuder, E., Kuti, D., Horvath, K., et al. (2020) Thrombocytosis and Effects of IL-6 Knock-Out in a Colitis-Associated Cancer Model. International Journal of Molecular Sciences, 21, Article No. 6218. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Bottsford-Miller, J., Choi, H., Dalton, H.J., Stone, R.L., Cho, M.S., Haemmerle, M., et al. (2015) Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer. Clinical Cancer Research, 21, 602-610. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Hu, Z., Tan, S., Chen, S., Qin, S., Chen, H., Qin, S., et al. (2020) Diagnostic Value of Hematological Parameters Platelet to Lymphocyte Ratio and Hemoglobin to Platelet Ratio in Patients with Colon Cancer. Clinica Chimica Acta, 501, 48-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Shi, K., Damhofer, H., Daalhuisen, J., ten Brink, M., Richel, D.J. and Spek, C.A. (2017) Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice. Molecular Medicine, 23, 13-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Yap, M.L., McFadyen, J.D., Wang, X., Zia, N.A., Hohmann, J.D., Ziegler, M., et al. (2017) Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging. Theranostics, 7, 2565-2574. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Giordano, A., Musumeci, G., D’Angelillo, A., Rossini, R., Biondi Zoccai, G., Messina, S., et al. (2016) Effects of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation and Beyond. Current Drug Metabolism, 17, 194-203. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Trikha, M., Zhou, Z., Timar, J., et al. (2002) Multiple Roles for Platelet GPIIb/IIIa and Alphavbeta3 Integrins in Tumor Growth, Angiogenesis, and Metastasis. Cancer Research, 62, 2824-2833.
|
|
[33]
|
Suzuki-Inoue, K. (2019) Platelets and Cancer-Associated Thrombosis: Focusing on the Platelet Activation Receptor CLEC-2 and Podoplanin. Blood, 134, 1912-1918. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Chang, Y., Hsieh, P., Chang, Y., Lu, M., Huang, T., Chong, K., et al. (2015) Identification of a Novel Platelet Antagonist That Binds to CLEC-2 and Suppresses Podoplanin-Induced Platelet Aggregation and Cancer Metastasis. Oncotarget, 6, 42733-42748. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Lucotti, S., Cerutti, C., Soyer, M., Gil-Bernabé, A.M., Gomes, A.L., Allen, P.D., et al. (2019) Aspirin Blocks Formation of Metastatic Intravascular Niches by Inhibiting Platelet-Derived Cox-1/Thromboxane A2. Journal of Clinical Investigation, 129, 1845-1862. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Rothwell, P.M., Wilson, M., Price, J.F., Belch, J.F., Meade, T.W. and Mehta, Z. (2012) Effect of Daily Aspirin on Risk of Cancer Metastasis: A Study of Incident Cancers during Randomised Controlled Trials. The Lancet, 379, 1591-1601. [Google Scholar] [CrossRef] [PubMed]
|